<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>BIOCARTA_CK1_PATHWAY</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            BIOCARTA_CK1_PATHWAY
        </div>
        <div class="card-body">
                <p>Cdk5 is a cyclin dependent protein kinase involved in dopaminergic signaling in the neostriatal region of the brain. The role of cdk5 in dopamine responses occurs through phosphorylation of DARPP-32. Caseine kinase 1 (CK1) also regulates DARPP-32 phosphorylation and dopamine signaling. The phosphorylation of DARPP-32 by cdk5 reduced dopamine signaling. Depending on its phosphorylation state, DARPP-32 inhibits either protein phosphatase 1 (PP1) or PKA. The role of mGLUR1 in this process is supported by the induction of cdk5 and CK1 activity by the mGLUR1 agonist DHPG and the subsequent phosphorylation of DARPP-32 associated with DHPG treatment of nigrostriatal neurons. CK-1 and Ckd5 inhibitors block the DHPG induced DARPP-32 phosphorylation. Dopamine exerts a positive signal that increases dopamine response by reversing phosphorylation of DARPP-32 at threonine-75. Dopamine initiates this pathway through activation of the D1 dopamine receptor, a Gs coupled GPCR, elevating cAMP and activating PKA. PKA activates protein phosphatase 2A (PP2A) which dephosphorylates DARPP-32 and increases dopamine responsiveness. This also removes the inhibition of PKA by DARPP-32, forming a positive feedback loop for further DARPP-32 inactivation by PKA. Activation of the D2 dopamine receptor has the opposite effect, shifting the DARPP-32 population toward the threonine-75 phosphorylated form.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M16626">M16626</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:1812">ncbigene:1812</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2911">ncbigene:2911</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1813">ncbigene:1813</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5515">ncbigene:5515</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5568">ncbigene:5568</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5573">ncbigene:5573</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:84152">ncbigene:84152</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23236">ncbigene:23236</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5577">ncbigene:5577</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5530">ncbigene:5530</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5567">ncbigene:5567</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8851">ncbigene:8851</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5575">ncbigene:5575</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1453">ncbigene:1453</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5576">ncbigene:5576</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1020">ncbigene:1020</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M16626&#39;, name=&#39;BIOCARTA_CK1_PATHWAY&#39;), definition=&#39;Cdk5 is a cyclin dependent protein kinase involved in dopaminergic signaling in the neostriatal region of the brain. The role of cdk5 in dopamine responses occurs through phosphorylation of DARPP-32. Caseine kinase 1 (CK1) also regulates DARPP-32 phosphorylation and dopamine signaling. The phosphorylation of DARPP-32 by cdk5 reduced dopamine signaling. Depending on its phosphorylation state, DARPP-32 inhibits either protein phosphatase 1 (PP1) or PKA. The role of mGLUR1 in this process is supported by the induction of cdk5 and CK1 activity by the mGLUR1 agonist DHPG and the subsequent phosphorylation of DARPP-32 associated with DHPG treatment of nigrostriatal neurons. CK-1 and Ckd5 inhibitors block the DHPG induced DARPP-32 phosphorylation. Dopamine exerts a positive signal that increases dopamine response by reversing phosphorylation of DARPP-32 at threonine-75. Dopamine initiates this pathway through activation of the D1 dopamine receptor, a Gs coupled GPCR, elevating cAMP and activating PKA. PKA activates protein phosphatase 2A (PP2A) which dephosphorylates DARPP-32 and increases dopamine responsiveness. This also removes the inhibition of PKA by DARPP-32, forming a positive feedback loop for further DARPP-32 inactivation by PKA. Activation of the D2 dopamine receptor has the opposite effect, shifting the DARPP-32 population toward the threonine-75 phosphorylated form.&#39;, provenance=[], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1812&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2911&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1813&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5515&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5568&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5573&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;84152&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23236&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5577&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5530&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5567&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8851&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5575&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1453&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5576&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1020&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CP:BIOCARTA&#39;], &#39;contributor&#39;: [&#39;BioCarta&#39;], &#39;external_details_url&#39;: [&#39;https://data.broadinstitute.org/gsea-msigdb/msigdb/biocarta/human/h_ck1Pathway.gif&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>